Cingulate Inc. Reports Third Quarter 2022 Financial Results and Provides Clinical and Business Update
14 nov. 2022 06h45 HE
|
Cingulate Inc.
Phase 3 Trial Initiation for Lead ADHD Candidate CTx-1301 in December 2022 Executed Manufacturing Agreement with Societal CDMO 2022 Psych Congress Presentation Demonstrated Ability of Anxiety...
PHP/IOP Behavioral Health Reacts to Maryland Teen Suffering in Waiting Room for 76 Days; Provides Critical Solution to Ongoing Crisis
02 nov. 2022 16h16 HE
|
Compass Health Center (compasshealthcenter.net)
CHICAGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- The Washington Post recently reported the story of Zachary Chafos, an 18-year-old who "languished for a total of 76 days in a Maryland ER waiting for a...
Workplace Options Acquires Rapid-Response Crisis Service The City Practice
01 nov. 2022 10h16 HE
|
Workplace Options
RALEIGH, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Workplace Options (WPO), a leading provider of holistic wellbeing solutions for more than 75 million people around the world, announced the...
Workplace Options Expands Global Footprint into Australian Market
01 nov. 2022 09h15 HE
|
Workplace Options
Leading provider of wellbeing solutions acquires EAP business of the Veretis Group RALEIGH, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Workplace Options (WPO), a leading provider of holistic...
Chicago Mental Health Experts Outline 7 Ways to Attain Balance for Improved Mental Health Throughout the Holiday Season
27 oct. 2022 15h16 HE
|
Compass Health Center (compasshealthcenter.net)
CHICAGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- A recent scientific brief released by the World Health Organization found that during the first year of the COVID-19 pandemic, the global prevalence of...
Cingulate Announces Agreement with Societal CDMO and Provides Clinical Update
24 oct. 2022 16h45 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study
24 oct. 2022 07h00 HE
|
Gb Sciences
LAS VEGAS, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Gb Sciences, Inc. ("GbS"; OTCQB:GBLX), a leading plant-inspired research and biopharmaceutical drug development company, has received positive...
Cingulate to Present at LD Micro Investor Conference
20 oct. 2022 14h20 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
13 oct. 2022 16h50 HE
|
Biomerica, Inc.
Notice of Patent Allowance in Australia containing broad claims pertaining to treating ADD/ADHD using the InFoods® Technology Notice of Patent Allowance in Japan containing broad claims pertaining to...
Chicago Behavior Center Utilizes Innovative Virtual Reality to Treat Obsessive-Compulsive Disorder and Anxiety Disorders
06 oct. 2022 16h01 HE
|
Compass Health Center (compasshealthcenter.net)
CHICAGO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Compass now offers Virtual Reality Care in its Adult Obsessive-Compulsive Disorder (OCD) and Complex Anxiety Programs across in-person locations and...